NCT01726452 NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS) Status COMPLETED Phase PHASE3
NCT01718873 Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT01716949 Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT01652482 Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC) Status COMPLETED Phase PHASE2
NCT01650428 Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery Status COMPLETED Phase PHASE2
NCT01634555 A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI Status COMPLETED Phase PHASE2
NCT01593020 Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 Status COMPLETED Phase PHASE2
NCT01590719 A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer Status COMPLETED Phase PHASE2
NCT01529164 Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT01525329 Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease Status TERMINATED Phase PHASE3
NCT01523431 Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients Status COMPLETED Phase PHASE2/PHASE3
NCT01498783 Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma Status COMPLETED Phase PHASE1
NCT01490866 A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC) Status COMPLETED Phase PHASE2
NCT01481545 Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer Status COMPLETED Phase PHASE2
NCT01411072 Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer Status UNKNOWN Phase NA
NCT01399684 A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01374425 Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC) Status COMPLETED Phase PHASE2